Consultant eye surgeon Faruque Ghanchi is pictured with (from left) Nicci Hawes, Charlotte Hazel, Zeid Madanat and Hayley Higgins and the new scanner in the eye clinic at Bradford Royal Infirmary.
Our eye research team unveiled their new £150,000 state-of-the-art scanner which will benefit hundreds of patients.
The Heidelberg retinal scanner, which is at the cutting edge of new technology, will lead to faster diagnosis and more precise treatment for conditions, including those linked to diabetes that can cause blindness.
Consultant eye surgeon Faruque Ghanchi said the machine marked an exciting new development for our clinical and research work, pushing the Foundation Trust even more to the forefront of eye research internationally and also enhancing patient care.
He said: "The new scanner, which is our second in recent years, will help us understand more about eye diseases and find more solutions.
"We are particularly fortunate in Bradford to have patients willing to help us with our research.
"We have been building up our research portfolio for the past ten years and this will put us even more at the forefront of eye research internationally, which means we can bring our patients the latest and most advanced assessments and treatments."
In the past six years, half a million pounds has been invested in eye research across our Foundation Trust.
The new scanner provides detailed and wider images of the patient's retina and means patients will no longer have to have injections of dye to show up how the blood vessels are working in the eye.
Faruque, who became the National Institute for Health Research's lead ophthalmic expert for industry studies last year, is also on a mission to attract more research opportunities from abroad to use the scanner which brings sponsorship with it.
Thousands of patients attend the eye clinic every year at BRI which attracts referrals from across Yorkshire because of our top equipment, services and expertise.
Faruque added: "The scanner will help us refine treatments and because of that reduce the treatments needed for our patients because we will have so much more detailed information available to us.
"It's a good foundation for us to work on and it shows how progressive our Trust is in its collaboration between research and clinical services."